Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vitamin C added to tranexamic acid for acute non-traumatic intracerebral hemorrhage
IRCT20170609034406N15Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ascorbic acid and tranexamic acid in intracerebral hemorrhage (ICH) and Intraventricular hemorrhage (IVH) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Prevention of intracerebral hemorrhage progression, Three-month functional outcome and 1 more. Started Jun 2026; status: completed.
02
Drugs
ascorbic acidtranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on IRCT20170609034406N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170609034406N15.